Epidemics
[대역어] 유행병
[용어속성] Term
[용어속성] Term
A qualitative study of the duty to care in communicable disease outbreaks
Article
[키워드] Canada
communicable diseases
Duty to care
empirical
Epidemics
health care providers
Qualitative
[DOI] 10.1016/j.socscimed.2007.07.017 PMC 바로가기 [Article Type] Article
[DOI] 10.1016/j.socscimed.2007.07.017 PMC 바로가기 [Article Type] Article
Response to Malaria Epidemics in Africa
아프리카 말라리아 전염병 대응
Perspective
[키워드] Epidemics
geographic information systems
malaria
Perspective
Prevention and control
sentinel surveillance
[DOI] 10.3201/eid1305.061333 PMC 바로가기 [Article Type] Perspective
[DOI] 10.3201/eid1305.061333 PMC 바로가기 [Article Type] Perspective
SARS-CoV replication and pathogenesis in an in vitro model of the human conducting airway epithelium
Article
[키워드] addition
airway
airway epithelial cells
airway epithelium
Antisera
apical surface
Atypical
Calu-3
Calu-3 cell
Cell
cells
cellular
Characteristics
ciliated
ciliated cell
consequence
coronavirus
coronavirus pathogenesis
Coronavirus replication
Culture
cultures
detected
develop
did not reduce
dry cough
efficient
enzyme
Epidemics
epithelial
epithelial cell
epithelial cell line
Experimental result
feature
Fever
fluorescent
Frame
GFP
hACE2
HAE
Human
human airway epithelia
human airway epithelial
Human airway epithelium
human lung
human pathogen
in vitro
in vitro model
in vivo
Infection
inoculated
insertion
late stage
log
Lower respiratory tract
lung
lung epithelial
mechanism
Morphological
new strain
onset of symptoms
ORF
Pathogenesis
pathology
physiological
Pneumonia
Post-infection
primary cell
progeny virion
Protein
provide
reached
receptor
reduced
replicate
replicated
Replication
reported
reservoir
respiratory virus
resulting
SARS Coronavirus
SARS-CoV
SARS-CoV GFP
SARS-CoV infection
Support
susceptible
target
tight junction
Trachea
Vero E6
viral infection
viral replication
viral titer
virus
wild type
zoonotic
[DOI] 10.1016/j.virusres.2007.03.013 PMC 바로가기 [Article Type] Article
[DOI] 10.1016/j.virusres.2007.03.013 PMC 바로가기 [Article Type] Article
Human Monoclonal Antibody Combination against SARS Coronavirus: Synergy and Coverage of Escape Mutants
Research Article
[키워드] 2003
acute respiratory syndrome
Administered
affected
against SARS-CoV
Alter
Amino acid
anti-SARS-CoV antibody
antibody
antibody concentration
Antigen
antigens
approach
arising
Bacteria
binding
blocked
Blood
breadth
carried
caused
center
China
close contact
close person-to-person contact
Combination
complementary
Concentration
Control
convalescent SARS patient
coronavirus
Coverage
CR3014
CR3022
died
different
disease
disease severity
dose
Effect
effective
Epidemic
Epidemics
epitope
escape
experiment
feasible
ferret
ferrets
finding
generate
glycoprotein
Guangdong
Health
healthy
Hong Kong
Human
human cell
human cells
human macrophage
Human monoclonal antibody
humans
immune
Immune escape
immunization
immunize
in vitro
individual effects
Infected
infecting
Infection
infectious
Infectious disease
information
interact
Interaction
International
killing
Laboratory
less
limit
lung damage
Lung pathology
mAb
mAbs
measure
monoclonal
monoclonal antibody
Mutation
neutralization
neutralized
NO
organism
Patient
pharyngeal
Prevent
prevented
prevention
producing
Prophylaxis
provided
quarantine
recognize
recognizing
reduce
reduction
repeated
replicated
required
Research
researcher
residue
responsible
SARS epidemic
SARS-CoV
SARS-CoV infection
screened
shown
sick
Spread
strain
suppress
synergistic
synergistic fashion
synergy
tested
the disease
the receptor-binding domain
Travel
treat
variant
variants
viral escape
viral spread
virus
Virus neutralization
virus strain
virus-neutralizing
viruses
website
Wikipedia
World Health Organization
[DOI] 10.1371/journal.pmed.0030237 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1371/journal.pmed.0030237 PMC 바로가기 [Article Type] Research Article
Molecular Epidemiology of SARS-associated Coronavirus, Beijing
Research
[키워드] amplified
amplified products
Beijing
Characteristics
clinical sample
Cluster
collected
coronavirus
different
dominant
Epidemics
geographic location
Guangdong
Host
immune pressure
isolate
loci
molecular
Molecular epidemiology
motif
Mutation
nucleotide
Patient
patients
reported
RT-PCR
RT-PCR, research
SARS-CoV
selective
sequence
Sequencing
Severe acute respiratory syndrome
single nucleotide variation
SNV
SNVs
to define
Variation
viral adaptation
were used
[DOI] 10.3201/eid1109.040773 PMC 바로가기 [Article Type] Research
[DOI] 10.3201/eid1109.040773 PMC 바로가기 [Article Type] Research
Molecular mechanisms of severe acute respiratory syndrome (SARS)
Review
[키워드] acute respiratory syndrome
approach
caused
contribute
coronavirus
Deleterious
Effect
effort
Epidemics
Features
Genome
Health
immune
immune system
indirect effect
infections
Infectious disease
Interaction
Laboratory
mechanism
molecular mechanisms
morbidity and mortality
mutability
Novel coronavirus
Occurrence
offer
Open reading frame
outbreak
Pathogenesis
Prevent
pulmonary pathological
Region
required
Research
Respiratory disease
SARS
SARS-CoV
severe
Severe acute respiratory syndrome
target cell
the disease
therapy
vaccination
Vaccine
viral genome
virulence
virus
widespread
[DOI] 10.1186/1465-9921-6-8 PMC 바로가기 [Article Type] Review
[DOI] 10.1186/1465-9921-6-8 PMC 바로가기 [Article Type] Review
Anti–SARS-CoV Immunoglobulin G in Healthcare Workers, Guangzhou, China
Research
[키워드] 2003
acute respiratory syndrome
antibody
China
determine
Epidemics
Guangzhou, China
healthcare
healthcare worker
Healthcare workers
healthy
hospital
Immunity
Immunoglobulin
Immunoglobulin G
Infection
infection control
measure
performed
Prevalence
Prevent
Research
SARS
SARS Coronavirus
SARS patient
SARS-CoV
Seroprevalence
Serosurvey
tested
[DOI] 10.3201/eid1101.040138 PMC 바로가기 [Article Type] Research
[DOI] 10.3201/eid1101.040138 PMC 바로가기 [Article Type] Research
In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds
Short Communication
[키워드] acute respiratory syndrome
antiviral activity
antiviral agent
Antiviral compound
Antiviral compounds
assay
cell line
cell lines
Checkerboard
Chinese
Combination
Compound
different
drug
Epidemics
glycyrrhizin
interferon
interferon-alpha
isolate
neutralisation test
performed
placebo controlled trial
plaque reduction assays
profile
Prophylaxis
randomised
Result
ribavirin
SARS Coronavirus
screened
selected
Severe acute respiratory syndrome
susceptibility
synergistic
synergy
Toxicity
Treatment
[DOI] 10.1016/j.jcv.2004.03.003 PMC 바로가기 [Article Type] Short Communication
[DOI] 10.1016/j.jcv.2004.03.003 PMC 바로가기 [Article Type] Short Communication